The court assigned to oversee the nationwide hernia patch and mesh lawsuits will hear claims of patients with both recalled and non-recalled hernia mesh and patch devices.
Over the last few years a number of patients have brought hernia mesh patch lawsuits against C.R. Bard, Inc., and Davol, Inc. alleging that their hernia mesh patch devices were defective and caused injuries. A large number of the claims were brought after an FDA hernia patch recall including claims based on defects in hernia mesh patches non-recalled hernia mesh patch devices.
Hernia patch lawsuits from across the United States have now been consolidated into a single court for all pretrial proceedings. In a recent ruling the court clarified the scope of the consolidated proceedings to include both recalled and non-recalled devices.
The federal Multi-District Litigation court has announced that it will hear hernia mesh and patch lawsuits involving both recalled and non-recalled devices manufactured by C.R. Bard, Inc., and Davol, Inc., including the following;
-All nine (9) models of Bard® ComposiX® Kugel® Hernia Patches (Product Codes 0010201 through 0010209);
-All other Davol hernia patches with PET rings, including the Bard® Kugel® Hernia Patch; Bard® VentraleX® Hernia Patch; Bard CK Parastomal Patch; and Bard® Modified Kugel™ Patch; and
-Other Davol hernia meshes composed of layers of polypropylene and ePTFE, including the Bard® Composix® E/X Mesh.